Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy
Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy · The Wall Street Journal

In This Article:

The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs.